Andrew Left, the founder of Citron Research, testified in a Los Angeles federal courtroom that his public statements about companies were never at odds with his actual trading positions, rebutting a core contention of the government's securities fraud case.
Left told jurors he did not speak negatively about a company while holding a long position, and he likewise denied ever promoting companies while in a short position. When defense lawyer Adam Fee asked whether he had ever been long a company and publicly spoken negatively about it, Left replied: "Never." He offered the same single-word response when questioned about being short while speaking positively.
The prosecution's case hinges on whether Left crossed the line from expressing opinion into manipulating markets. Prosecutors assert that internal messages show Left conveyed different information privately than he did to the public, and that he used social media to move prices for personal gain.
Among the allegations presented to the jury is an October 2018 episode involving Tesla Inc., which the government says involved Left promoting a long position in the electric-vehicle maker and then quickly selling shares after his commentary helped push the stock higher. Left countered during his testimony that trimming a long stake is a distinct action from entering a short position.
Prosecutors displayed emails they contend document coordination between Left and hedge funds regarding stocks he intended to short, arguing this corroborates a pattern of deceptive conduct. The jury also heard testimony from Mike Gorenstein, chief executive of Cronos Group Inc., who recounted a sharp drop in his company's share price after Left published a report calling the cannabis distributor overvalued.
Asked whether Gorenstein's courtroom account caused him to question the accuracy of his own report on Cronos, Left responded: "Everything he said in this trial validated everything I wrote in that report."
Left, 55, has denied misleading investors and asserts his trading activity did not create obligations for public disclosure. The defense presented his testimony as a direct repudiation of the prosecution's claim that his public commentary and private trading were at odds.
Following the defense testimony, prosecutors are expected to cross-examine Left. Jurors could begin deliberations later this week, according to statements in court, as the trial moves toward resolution.
Key points
- Andrew Left testified he never spoke negatively about companies he held long positions in, nor spoke positively about firms he was shorting.
- The government alleges Left used social media and private communications to move stock prices and profit from those moves, including an October 2018 incident involving Tesla.
- Testimony from Cronos Group's CEO said shares fell after Left's report; Left said that testimony supported his report's conclusions.
Risks and uncertainties
- Legal uncertainty over whether public commentary by market participants constitutes unlawful manipulation - this primarily affects market participants and the financial sector.
- Potential market reputation effects for companies targeted by activist short reports, as illustrated by testimony about Cronos Group's share price decline - this impacts the cannabis sector and public companies more broadly.
- Ongoing trial proceedings and additional testimony could change the case timeline and influence investor attention until jurors reach a verdict.